Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-01-29
1989-03-14
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514389, 514452, 514530, 544 39, 548313, 549363, 560119, 560121, C07C17700, A61K 31557
Patent
active
048124575
ABSTRACT:
Permeability characterized in that the carboxy group at 1-position of the prostaglandin is combined with a cell membrane permeable substance having hydroxy group or amino group through the intermediation of an ester bond to the hydroxy group or an amide bond to the amino group are novel and have improved cell membrane permeability.
REFERENCES:
Kirk-Othmer, Encylopedia of Chemical Technology, 3rd Ed., Supplement vol. 1984, pp. 711-752.
Chem. Abstr., vol. 96, No. 19, p. 178, abstract No. 156368u, 5/82.
Chem. Abstr. vol. 97. No. 7, p. 252, abstract No. 51485x, 8/82.
Hatsumi, J of Chrom. 253, 271 (1982).
Hayaishi Osamu
Kimura Yoshiharu
Narumiya Shuh
Tsuboshima Masami
Gerstl Robert
Research Development Corporation
Tsuboshima Masami
LandOfFree
Prostaglandin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-893919